TGen News & Press Releases

PepSeq Provides Massive Platform for Antibody Analyses

Posted Monday December 5, 2022

Technology developed at TGen described in new study

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

Posted Tuesday November 22, 2022

TGen’s 17th Annual Step-N-Out 5K ‘FUNdraiser’ Kicks Off Pancreatic Cancer Awareness Month

Posted Wednesday November 2, 2022

For one volunteer, participation goes beyond raising money for research and clinical trials for pancreatic cancer, it’s a way to give back and honor a loved one

TGen Foundation’s 2nd annual Runway for Research takes place Friday, October 14

Posted Friday October 7, 2022

$2 Million SBIR direct to phase II award funds therapeutic development and testing at Stingray Therapeutics and TGen

Posted Tuesday October 4, 2022

TGen, ASU, and Phoenix Children’s collaborate to better diagnose and treat disease affecting Latino youth

Posted Wednesday September 28, 2022

A new grant from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) will help researchers from TGen, ASU, and Phoenix Children’s better understand fatty liver disease in Latino youth with obesity.

Deep Proteomic Profiling Reveals Possible Therapeutic Targets for Medulloblastoma